Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Jommi

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Clinical Therapeutics|December 29, 2019
Implementation of Value-based Pricing for MedicinesClaudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Global & Regional Health Technology Assessment|January 22, 2026
Claudio Jommi, Barbara Rebesco, Francesco Perrone, et al.
Social Science & Medicine (1982)|December 26, 2016
The impact of HTA and procurement practices on the selection and prices of medical devicesGiuditta Callea, Patrizio Armeni, Marta Marsilio, et al.
Journal of Market Access & Health Policy|May 27, 2026
Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and ConsistencyAlvise Verde, Federica Turati, Clara Trimarchi, et al.
Health Policy (Amsterdam, Netherlands)|July 16, 2013
Multi-tier drugs assessment in a decentralised health care system. The Italian case-studyClaudio Jommi, Enrico Costa, Alessandra Michelon, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Claudio Jommi, Patrizio Armeni, Arianna Bertolani, et al.
BMC Health Services Research|December 5, 2021
The economic impact of compassionate use of medicinesClaudio Jommi, Federico Pantellini, Lisa Stagi, et al.
Applied Health Economics and Health Policy|November 26, 2022
EQ-5D-5L Population Norms for ItalyMichela Meregaglia, Francesco Malandrini, Aureliano Paolo Finch, et al.
Journal of Pharmaceutical Policy and Practice|March 20, 2021
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?Virginia Ronco, Myriam Dilecce, Elena Lanati, et al.
Social Science & Medicine (1982)|November 5, 2021
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administrationAureliano Paolo Finch, Michela Meregaglia, Oriana Ciani, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Clinical Therapeutics|December 29, 2019
Implementation of Value-based Pricing for MedicinesClaudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Global & Regional Health Technology Assessment|January 22, 2026
Claudio Jommi, Barbara Rebesco, Francesco Perrone, et al.
Social Science & Medicine (1982)|December 26, 2016
The impact of HTA and procurement practices on the selection and prices of medical devicesGiuditta Callea, Patrizio Armeni, Marta Marsilio, et al.
Journal of Market Access & Health Policy|May 27, 2026
Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and ConsistencyAlvise Verde, Federica Turati, Clara Trimarchi, et al.
Health Policy (Amsterdam, Netherlands)|July 16, 2013
Multi-tier drugs assessment in a decentralised health care system. The Italian case-studyClaudio Jommi, Enrico Costa, Alessandra Michelon, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Claudio Jommi, Patrizio Armeni, Arianna Bertolani, et al.
BMC Health Services Research|December 5, 2021
The economic impact of compassionate use of medicinesClaudio Jommi, Federico Pantellini, Lisa Stagi, et al.
Applied Health Economics and Health Policy|November 26, 2022
EQ-5D-5L Population Norms for ItalyMichela Meregaglia, Francesco Malandrini, Aureliano Paolo Finch, et al.
Journal of Pharmaceutical Policy and Practice|March 20, 2021
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?Virginia Ronco, Myriam Dilecce, Elena Lanati, et al.
Social Science & Medicine (1982)|November 5, 2021
An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administrationAureliano Paolo Finch, Michela Meregaglia, Oriana Ciani, et al.
Pageof 9